SCHEMBL2172190

SCHEMBL2172190

COc1cccc(C(=O)NS(C)(=O)=O)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.62
RAB9A P51151 6/20 0.62
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
SCN2B O60939 1/20 0.59
SCN1A P35498 1/20 0.59
SCN1B Q07699 1/20 0.59
SCN5A Q14524 1/20 0.59
SCN9A Q15858 1/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
CES2 O00748 1/20 0.59
CES1 P23141 1/20 0.59
KAT6A Q92794 1/20 0.58
TSHR P16473 2/20 0.57
NPSR1 Q6W5P4 1/20 0.57
RXFP1 Q9HBX9 1/20 0.56
TP53 P04637 3/20 0.56
ALDH1A1 P00352 2/20 0.56
KCNK3 O14649 1/20 0.56
KCNK9 Q9NPC2 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986975 0.84 NPC1 (0.59) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL680286 0.84 PGR (0.60) NPC1RAB9AKMT2ASCN2BSCN1A
SCHEMBL7985860 0.83 KAT6A (0.61) NPC1RAB9AKMT2ASMN1; SMN2KAT6A
SCHEMBL1012519 0.83 NPC1 (0.70) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL2159384 0.82 POLB (0.62) NPC1RAB9AMEN1KMT2ASCN2B
SCHEMBL12871351 0.81 NPC1 (0.90) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL31516646 0.81 KAT6A (0.55) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL7973370 0.81 TAS1R3 (0.58) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL679751 0.80 SCN9A (0.58) MEN1KMT2ASCN2BSCN1ASCN1B
SCHEMBL7973298 0.80 SMPD1 (0.67) MEN1KMT2AKAT6AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116870016-B Heteroaromatic compound and medical application thereof 希格生科(深圳)有限公司 2024-05-28 CN disclosed
CN-117412981-A Phosphine oxide derivative and preparation method and application thereof 希格生科(深圳)有限公司 2024-01-16 CN disclosed
CN-116870016-A Heteroaromatic compound and medical application thereof 希格生科(深圳)有限公司 2023-10-13 CN disclosed
CN-115785154-A Heteroaromatic ring compounds and medical use thereof 希格生科(深圳)有限公司 2023-03-14 CN disclosed
WO-2015051043-A1 BIARYL ACYL-SULFONAMIDE COMPOUNDS AS SODIUM CHANNEL INHIBITORS AMGEN INC. (US) 2015-04-09 WO disclosed
EP-2346868-A1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-07-27 EP disclosed
WO-2010036632-A1 AZAINDAZOLE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed